CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Open-market sale Director sold 15,174 shares at an average $43.80 ($664,601)
- 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $45.03 ($61,916)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $46.03 ($63,291)
- 4 Open-market sale EVP, Research & CSO sold 7,900 shares at $49.50 ($391,077)
- 4 Open-market sale EVP, Research & CSO sold 2,340 shares at $48.00 ($112,320)
- 4 Option exercise EVP, Research & CSO acquired 3,500 shares (option exercise)
- 4 Open-market sale EVP, Research & CSO sold 5,560 shares at $43.57 ($242,244)
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Other events
- 4 Option exercise EVP, Research & CSO acquired 14,000 shares (option exercise)
- 4 Other disposition Director disposed of 1,000,000 shares (other)
- 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale Chief Business Officer sold 6,944 shares at $51.40 ($356,956)
- 4 Other disposition Director disposed of 1,000,000 shares (other)
- 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
- 4 Grant or award Chief Technology Officer acquired 30,000 shares (grant or award)
Page 29 of 41 · 806 filings